JP2016044170A5 - - Google Patents

Download PDF

Info

Publication number
JP2016044170A5
JP2016044170A5 JP2014172328A JP2014172328A JP2016044170A5 JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5 JP 2014172328 A JP2014172328 A JP 2014172328A JP 2014172328 A JP2014172328 A JP 2014172328A JP 2016044170 A5 JP2016044170 A5 JP 2016044170A5
Authority
JP
Japan
Prior art keywords
stearic acid
excipient
olmesartan medoxomil
granulated product
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014172328A
Other languages
English (en)
Japanese (ja)
Other versions
JP6653116B2 (ja
JP2016044170A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014172328A priority Critical patent/JP6653116B2/ja
Priority claimed from JP2014172328A external-priority patent/JP6653116B2/ja
Publication of JP2016044170A publication Critical patent/JP2016044170A/ja
Publication of JP2016044170A5 publication Critical patent/JP2016044170A5/ja
Application granted granted Critical
Publication of JP6653116B2 publication Critical patent/JP6653116B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014172328A 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤 Active JP6653116B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014172328A JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019089234A Division JP6765473B2 (ja) 2019-05-09 2019-05-09 オルメサルタンのプロドラッグ製剤

Publications (3)

Publication Number Publication Date
JP2016044170A JP2016044170A (ja) 2016-04-04
JP2016044170A5 true JP2016044170A5 (OSRAM) 2017-08-24
JP6653116B2 JP6653116B2 (ja) 2020-02-26

Family

ID=55635052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014172328A Active JP6653116B2 (ja) 2014-08-27 2014-08-27 オルメサルタンのプロドラッグ製剤

Country Status (1)

Country Link
JP (1) JP6653116B2 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME03654B (me) 2014-02-13 2020-07-20 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
PT3105226T (pt) 2014-02-13 2019-11-06 Incyte Corp Ciclopropilaminas como inibidores de lsd1
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
AU2016243939B2 (en) 2015-04-03 2020-09-03 Incyte Holdings Corporation Heterocyclic compounds as LSD1 inhibitors
KR102710120B1 (ko) 2015-08-12 2024-09-27 인사이트 홀딩스 코포레이션 Lsd1 저해제의 염
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
JP6765473B2 (ja) * 2019-05-09 2020-10-07 日本ケミファ株式会社 オルメサルタンのプロドラッグ製剤
KR20220129538A (ko) * 2020-01-16 2022-09-23 에자이 알앤드디 매니지먼트 가부시키가이샤 렘보렉산트의 약물 물질 및 이를 포함하는 의약 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123765A1 (ja) * 2005-05-20 2006-11-23 Daiichi Sankyo Company, Limited フィルムコーティング製剤
US20070105923A1 (en) * 2005-09-14 2007-05-10 Glenmark Pharmaceuticals Limited Substantially pure olmesartan medoxomil and processes for its preparation
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil
JPWO2008117707A1 (ja) * 2007-03-23 2010-07-15 第一三共株式会社 オルメサルタンメドキソミルの粉砕結晶
JP5688799B2 (ja) * 2008-08-11 2015-03-25 第一三共株式会社 におい抑制方法
EA201170913A1 (ru) * 2008-12-30 2012-01-30 Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты Фармацевтические составы олмесартана
HUP0900384A2 (en) * 2009-06-19 2011-01-28 Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag Nanoparticulate olmesartan medoxomil compositions
WO2011045760A2 (en) * 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Micronized olmesartan medoxomil compositions
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
WO2014080365A1 (en) * 2012-11-23 2014-05-30 Ranbaxy Laboratories Limited Method of reducing an unpleasant odor of a pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2016044170A5 (OSRAM)
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
JP2015078230A5 (OSRAM)
JP2014221779A5 (OSRAM)
RU2011141496A (ru) Таблетки и гранулированные порошки, содержащие 6-фтор-3-гидрокси-2-пиразинкарбоксамид
MX2013014788A (es) Liberacion modificada de 4-metil-3-[[4-(3-piridinl)-2-pirimidinil] -amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil ]-benzamida solubilizada utilizando acidos organicos.
RU2020119391A (ru) Получение тетрациклического соединения, содержащегося в высокой дозе
IL233830B (en) Preparations of 3-(6-(1-(2,2-difluorobenzo{0}{1,3}dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid, methods for their staining and uses thereof
EP4349406A3 (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole for use as a medicament
HK1232218A1 (zh) Cgrp-活性化合物的片剂制剂
RU2019138248A (ru) Фармацевтическая композиция для перорального введения, содержащая энзалутамид
AR121624A2 (es) Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
EP4327880A3 (en) Solid state form of ribociclib succinate
MX2008011579A (es) Forma galenica divisible que permite una liberacion modificada del principio activo.
PH12019500610A1 (en) Controlled release tablet based on polyvinyl alcohol and its manufacturing
IN2014DE03239A (OSRAM)
EA201500513A1 (ru) Продукт сомикронизации, включающий ацетат улипристала
JP2017515879A5 (OSRAM)
JP2014024874A5 (OSRAM)
WO2012053785A3 (ko) 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛
JP2014218523A5 (OSRAM)
JP2015129175A5 (OSRAM)
JP2014062064A5 (OSRAM)
JP2015129124A5 (OSRAM)